"they want to stay in the hospital..." by what authority do you make this statement? I actually LIVE in Europe, and that's boloney. People generally want to get out of the hospitals and, who the heck wants to be on an IV when they can be on an oral version? Good grief, you are obviously playing with us, and this is the last time I'm responding to you. But wanted to make sure NOONE thinks you are making sense! By the way, cut out the personal digs at the ceo. She's doing a sterling job.
Seriously? Just be careful (if that comment is for real, you're just gambling). Losing a lot of money in this economy, on poor judgment, is very dangerous - especially if you're shorting on margin.
wonder if she got all her wall street contributions, before sending that tweet. US is one of few countries actually doing research in pharma...pretty much no other country can afford it!
just traders and eft's messing with the stock. In fact, I think some of us should notify the sec because it seems like blatant manipulation.
$27,000 worth, most are just $100 sells as I'm watching on level 2. There is no bad news, so perhaps nerves before announcement, with the occasional large buy. Nasdaq's down, stock is volatile because of low float.
Lurker, please don't respond to me. I have ZERO respect for you, in fact, I'm just putting you on ignore. Fed up with your nonsense.
From the fda site: A Priority Review designation is given to drugs that offer major advances in treatment, or provide a treatment where no other adequate therapy exists. These drugs could earn six-month review (Priority Review is generally given to fast-track designated drugs).
Priority Review shortens the target period for FDA review from 10 months to 6 months, and this designation is often used in combination with other expedited review processes